相关实验视频

Updated: Jun 25, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

在肝细胞癌中探索非编码RNA机制:对治疗和预后的影响

Yu Tian^1,2, Meng Zhang³, Li-Xia Liu⁴

¹Research Center, The Huizhou Central People's Hospital, Guangdong Medical University, Huizhou, Guangdong, China.

Frontiers in immunology

|May 27, 2024

概括

非编码RNAs (ncRNAs) 是肝细胞癌 (HCC) 发展的关键调节剂. 了解它们的异常表达为新生物标志物和HCC治疗中的精准医学策略提供了潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学遗传学是一个

背景情况:

肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
非编码RNAs (ncRNAs) 的异常调节,包括microRNAs (miRNAs),长非编码RNAs (lncRNAs) 和循环RNAs (circRNAs),都与HCC的发展和进展有关.
ncRNAs在调节基因表达方面发挥着关键作用,影响细胞增殖,细胞亡和转移等关键癌症途径.

研究的目的:

探索ncRNAs在肝细胞癌 (HCC) 中的作用.
突出ncRNAs作为HCC的诊断,预后和治疗点的潜力.
强调ncRNA驱动的监管系统在了解HCC生物学和治疗反应方面的重要性.

主要方法:

审查目前关于ncRNA表达和功能在HCC的研究.
分析miRNAs和lncRNAs如何影响与癌症相关的基因表达和细胞过程.
对ncRNAs在HCC中的精密医学方法的潜力进行调查.

主要成果:

ncRNAs 的异常表达是 HCC 的标志.
miRNAs通过调节与癌症相关的基因,可以作为瘤抑制剂或瘤基因.
lncRNAs通过影响染色体重塑,转录和转录后修饰的相互作用影响癌症进展.

结论:

ncRNAs是HCC的关键调节者,为诊断和预后提供潜在的生物标志物.
针对ncRNA调节网络为新型HCC疗法提供了一个有希望的途径.
将ncRNA研究整合到精准医学中可以显著改善HCC患者的治疗结果.

关键词:

诊断和预后诊断和预后表观遗传因素是表观遗传的因素.肝细胞癌是肝细胞癌.这是一个miRNA海绵.治疗耐药性治疗耐药性

更多相关视频

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Types of RNA

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...